Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minimally Invasive Sleep Solutions (MISleep) is a healthcare company dedicated to providing advanced, office-based treatments for obstructive sleep apnea (OSA) and snoring. The company specializes in minimally invasive procedures that serve as alternatives to traditional CPAP therapy and invasive surgeries, such as radiofrequency tissue reduction and palatal implants. By focusing on airway stabilization and patient-specific diagnostics, MISleep aims to improve treatment compliance and overall sleep quality. Their clinical model integrates diagnostic sleep studies with specialized procedural interventions to offer a comprehensive care pathway for sleep-disordered breathing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MISleep Solution.